Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Huazhuo Decoction is a traditional Chinese medicine (TCM) herbal formula used primarily for the management of metabolic and cardiovascular diseases. It is composed of multiple Chinese herbs designed to "invigorate qi" (vital energy) and "remove turbidity," reflecting TCM principles. Clinical studies indicate that it can reduce blood glucose, glycated hemoglobin, body weight, and insulin resistance in patients with type 2 diabetes mellitus[1]. The decoction has also been studied for its effects on chronic heart failure when combined with conventional Western therapies[3]. Mechanistically, it appears to act through multi-target pathways including improving endothelial function, reducing inflammation and oxidative stress, modulating apoptosis-related signaling (such as AKT1 and RAS pathways), enhancing insulin secretion from pancreatic beta cells, and protecting organ tissues from injury[1][3][5]. Its composition may include herbs such as Astragalus membranaceus (Huangqi), Angelica sinensis (Danggui), licorice root (Gancao), among others—though exact ingredients can vary by formulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqi Huazhuo Decoction.